In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF
Launched by HILLEL YAFFE MEDICAL CENTER · Nov 19, 2007
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy women diagnosed with Polycystic Ovarian Syndrome with BMI 18-30 kg/sqm, aged 20-35
- Exclusion Criteria:
- • Every one else
About Hillel Yaffe Medical Center
Hillel Yaffe Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Hadera, Israel, the center is committed to fostering cutting-edge scientific inquiry and collaboration across various medical disciplines. With a focus on patient safety and ethical standards, Hillel Yaffe Medical Center actively engages in the development of novel therapies and treatment modalities, aiming to enhance health outcomes and contribute to the global medical community. The center prides itself on its multidisciplinary approach, integrating expertise from experienced researchers and clinicians to drive impactful studies that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hadera, , Israel
Patients applied
Trial Officials
Adrian Ellenbogen, MD
Study Director
IVF Unit, Hillel Yaffe Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials